Drugs / Huaier Granule

Trials 23 · a red edge is where a trial was stopped

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 22 trials
Phase 2 NCT07413354 Apr 2026 → Mar 2027 expected hepatocellular carcinoma Tongji Hospital Recruiting No outcome recorded
Phase 2 NCT05673824 Jan 2023 → Sep 2025 poisoning Fudan University Completed No outcome recorded
Phase 2/31 trial
Phase 2/3 NCT04291053 Apr → Aug 2020 COVID-19 Tongji Hospital Unknown No outcome recorded
Phase 33 trials
Phase 3 NCT07197853 Oct 2025 → Jun 2028 expected non-small cell lung carcinoma Xin Ye Not yet recruiting No outcome recorded
Phase 3 NCT02796820 Jun 2016 → Jan 2018 colorectal cancer Sixth Affiliated Hospital, Sun Yat-sen University Unknown No outcome recorded
Phase 3 NCT02785146 Jun 2016 → Jan 2018 colorectal cancer Sixth Affiliated Hospital, Sun Yat-sen University Unknown No outcome recorded
Phase 414 trials
Phase 4 NCT07358520 Jan 2026 → Jan 2027 expected proteinuria Fudan University Not yet recruiting No outcome recorded
Phase 4 NCT05871437 Sep 2025 → Jan 2026 overdue breast cancer Fudan University Not yet recruiting No outcome recorded
Phase 4 NCT06090994 Oct 2024 → Jul 2027 expected colorectal cancer Fudan University Recruiting No outcome recorded
Phase 4 NCT06665334 Oct 2024 → Oct 2026 expected colorectal cancer Fudan University Not yet recruiting No outcome recorded
Phase 4 NCT05498766 Jul 2024 → Jul 2029 expected gastric cancer Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Not yet recruiting No outcome recorded
Phase 4 NCT06368063 May 2024 → Mar 2026 overdue pancreas disorder Xi'an Jiaotong University Recruiting No outcome recorded
Phase 4 NCT06387368 May 2024 → Mar 2028 expected malignant pancreatic neoplasm Xi'an Jiaotong University Not yet recruiting No outcome recorded
Phase 4 NCT05860907 Oct 2023 → Oct 2025 overdue breast cancer Fudan University Not yet recruiting No outcome recorded
Phase 4 NCT05839314 May 2023 → May 2027 expected idiopathic membranous glomerulonephritis Chinese PLA General Hospital Recruiting No outcome recorded
Phase 4 NCT04790305 Jun 2021 → Dec 2027 expected invasive ductal breast carcinoma, triple-negative breast carcinoma Fudan University Recruiting No outcome recorded
Phase not applicable3 trials
NCT05792254 May → Dec 2023 fallopian tube cancer, ovarian cancer, peritoneum cancer Ruijin Hospital Unknown No outcome recorded
NCT05749211 May → Dec 2023 ovarian cancer Ruijin Hospital Unknown No outcome recorded
NCT03198117 Apr → Nov 2017 non-small cell lung carcinoma Qidong Gaitianli Medicines Co., Ltd Terminated No outcome recorded
Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT07355361 Comparator Jan 2026 → Jun 2027 expected female breast carcinoma, proteinuria Fudan University Not yet recruiting No outcome recorded

Evidence & citations 6 cited values

Every value below carries the sentence it was read from. 25 sources stand behind the page.

FieldValueCited text
Known as Huaier Granule “Drug: Huaier granuleNCT06665334
23

NCT04790305

NCT05749211

NCT05792254

NCT01770431

NCT05839314

NCT06090994

NCT02796820

NCT01760616

NCT02615457

NCT07355361

NCT03198117

NCT02627248

NCT07358520

NCT07197853

NCT02785146

NCT05498766

NCT05871437

NCT05860907

NCT06368063

NCT06387368

NCT07413354

NCT05673824

NCT04291053

Known as Huaier Granules Huaier Granules: Oral administration, 10g once, 3 times a day.” NCT06387368
Known as Z20000109 “Huaier Granule Group: Participants will take Huaier Granule (Z20000109) on top of their standard treatment.” NCT07355361
Action Inhibit “It was observed that the Huaier extract significantly inhibited the spheroid formation potential (P<0.05) and decreased the aldehyde dehydrogenase (ALDH)-positive cell...” PMID 23599758 Jan 2013
Modality Traditional medicine (herbal / TCM) “Huaier Granule is a Chinese medicine” NCT01760616
Route Oral “the Huaier Granule Electuary should be orally taken from the 15th day after surgery” NCT01760616